Treatment for Chagas Disease involves a combination of methods that kill the parasite and manage the signs and symptoms. The disease can be either short-term or chronic, with the acute form of the disease usually disappearing on its own. The chronic form, however, requires ongoing treatment to avoid further infection.
Chagas Disease is caused by the protozoan Trypanosoma cruzi and is endemic to much of the Americas, including Argentina and Chile. The disease was named after Carlos Chagas, a Brazilian bacteriologist who discovered the modern form of the disease in 1908. Today, nearly 8 million people in over 50 countries around the world have the parasite, and it’s responsible for over 10,000 deaths every year. The disease is transmitted by contact with triatomine bugs, which are found in the soil of the southern United States. Although it is uncommon in the United States, it’s estimated that approximately 8 million people in these countries are infected. If left untreated, Chagas disease can lead to death.
Request Here For The Sample Copy Of The Report @ https://www.coherentmarketinsights.com/insight/request-sample/934
Growing drug approval for Chagas disease is expected to be a major factor driving growth of the Chagas disease treatment market. For instance, in August 2020, The U.S. Food and Drug Administration approved the use of Bayer AG’s Lampit to treat Chagas disease in children. Lampit, or nifurtimox, can also be used by patients under the age of 18 and weighing at least 2.5 kilograms. Hence, approval of Chagas disease treatment drugs in such key regions is expected to drive growth of global Chagas disease treatment market in the near future.
Growing R&D activities by key players for developing for novel Chagas disease treatment is again expected to drive growth of market. For instance, in April 2020, Daiichi Sankyo has renewed a joint research agreement with the Drugs for Neglected Diseases initiative (hereinafter, “DNDi”) with regard to a new research program, the Lead Optimization Project, with the aim of developing innovative drug treatments for Chagas disease, one of the neglected tropical diseases. The development of such vaccine is expected to create an opportunity for key players to enter in this market. In 2016, Drugs for Neglected Diseases sponsored the clinical trial of Benznidazole in combination with E1224 (fosravuconazole) aiming to improve treatment for Chagas disease. The combination is in Phase 2 clinical trial. Furthermore, increasing launches of novel diagnostic methods such as rapid diagnostic test, and ELISA is expected to increase diagnosis rate for Chagas disease, which in turn is expected to increase demand for its treatment drugs. For instance, in 2016, InBios International, Inc. received 510K clearance from the U.S. Food and Drug Administration (FDA) for its Chagas Detect Plus Rapid Test Kit (CDP).
Key Takeaways of the global Chagas Disease Treatment Market:
- The global Chagas disease treatment market is expected to exhibit a CAGR of 7.3% over the forecast period (2017–2025), owing to increasing approval of Chagas disease treatment drugs in key regions. For instance in 2017, U.S. FDA approved benznidazole in the U.S. for treatment of Chagas disease
- North America is expected to witness highest growth over the forecast period. This is due to growing approvals of treatment drugs for Chagas such as benznidazole in 2017, in the U.S. Benznidazole is the only FDA approved treatment indicated for the treatment of Chagas disease.
- Market players in the market are focusing on gaining approvals for novel Chagas disease treatment drugs. For instance, in 2016, Drugs for Neglected Diseases sponsored the clinical trial of Benznidazole in combination with E1224, with an objective to improve treatment for Chagas disease. The combination is in Phase 2 clinical trial.
- Various private and government organizations are taking initiatives to increase the awareness about Chagas disease and to increase its treatment rate. In April 2018, an international humanitarian organization, Médecins Sans Frontières/Doctors Without Borders (MSF), launched a campaign to increase awareness about the diagnosis and treatment of Chagas disease among Latin American population.
- Key players operating in the Chagas disease treatment market include Nortec Quimica SA, Bayer AG, Laboratorio Elea Phoenix SA, Maprimed S.A., and Laboratório Farmacêutico de Pernambuco S/A.
Request Here PDF Brochure Of This Report @ https://www.coherentmarketinsights.com/insight/request-pdf/934
Table of Content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Chagas Disease Treatment Market Size Analysis from 2022 to 2028
11.6 COVID-19 Outbreak: Chagas Disease Treatment Industry Impact
Chapter 2 Global Chagas Disease Treatment Competition by Types, Applications, and Top Regions and Countries
2.1 Global Chagas Disease Treatment (Volume and Value) by Type
2.3 Global Chagas Disease Treatment (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Chagas Disease Treatment Sales, Consumption, Export, Import by Regions (2017-2022)
Chapter 5 North America Chagas Disease Treatment Market Analysis
Chapter 6 East Asia Chagas Disease Treatment Market Analysis
Chapter 7 Europe Chagas Disease Treatment Market Analysis
Chapter 8 South Asia Chagas Disease Treatment Market Analysis
Chapter 9 Southeast Asia Chagas Disease Treatment Market Analysis
Chapter 10 Middle East Chagas Disease Treatment Market Analysis
Chapter 11 Africa Chagas Disease Treatment Market Analysis
Chapter 12 Oceania Chagas Disease Treatment Market Analysis
Chapter 13 South America Chagas Disease Treatment Market Analysis
Chapter 14 Company Profiles and Key Figures in Chagas Disease Treatment Business
Chapter 15 Global Chagas Disease Treatment Market Forecast (2022-2028)
Chapter 16 Conclusions
Research Methodology
Direct Buy This Premium Research Report, Click Here @ https://www.coherentmarketinsights.com/insight/buy-now/934
About US
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com